Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 699
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +20.3%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 2,101–2,131 of 2,131 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00653978	Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures	unknown	Phase 3	150	Changhai HospitalOTHER	2	Jun 22, 2011	clinicaltrials
NCT00500968	Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail	completed	N/A	50	Karolinska InstitutetOTHER	1	Apr 7, 2011	clinicaltrials